Jorey Chernett (NASDAQ: KZIA) reports multi-million ADS stake

Rhea-AI Filing Summary

KAZIA THERAPEUTICS LTD (KZIA) received an amended Schedule 13G/A indicating that investor Jorey Chernett beneficially owns a significant stake in the company’s American Depositary Shares (ADS).

As of the close of business on August 19, 2026, Chernett beneficially owned 2,339,009 ADS, representing 19.6% of the ADS class, based on 11,926,899 ADS outstanding as of the same date. Chernett reports sole voting and sole dispositive power over all 2,339,009 ADS, with no shared voting or dispositive power.

Key Figures

Beneficial ownership: 2,339,009 ADS Percent of class: 19.6% ADS outstanding: 11,926,899 ADS +2 more

5 metrics

Beneficial ownership 2,339,009 ADS American Depositary Shares beneficially owned by Jorey Chernett as of August 19, 2026

Percent of class 19.6% Percentage of KAZIA ADS class beneficially owned by Jorey Chernett

ADS outstanding 11,926,899 ADS American Depositary Shares outstanding as of August 19, 2026, assuming all ordinary shares represented by ADS

Sole voting power 2,339,009 ADS Number of ADS over which Chernett has sole power to vote

Sole dispositive power 2,339,009 ADS Number of ADS over which Chernett has sole power to dispose

Key Terms

beneficially owned, American Depositary Shares, CUSIP No., Sole Voting Power, +1 more

5 terms

beneficially owned financial

"As of the close of business on August 19, 2026, the Reporting Person beneficially owned 2,339,009 ADS"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

American Depositary Shares financial

"The aggregate percentage of American Depositary Shares ("ADS") owned by the Reporting Person is calculated"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

CUSIP No. financial

"Title of class of securities: American Depositary Shares (e) | CUSIP No.: 48669G105"

Sole Voting Power financial

"5 | Sole Voting Power 2,339,009.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"7 | Sole Dispositive Power 2,339,009.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

What percentage of KZIA does Jorey Chernett report owning in this Schedule 13G/A?

Jorey Chernett reports beneficial ownership of 19.6% of KAZIA THERAPEUTICS LTD’s American Depositary Shares. This percentage is based on 11,926,899 ADS outstanding as of August 19, 2026, as provided to him by the company.

How many KZIA American Depositary Shares does Jorey Chernett beneficially own?

Jorey Chernett beneficially owns 2,339,009 KAZIA THERAPEUTICS LTD American Depositary Shares. This ownership reflects his position as of the close of business on August 19, 2026, according to the Schedule 13G/A amendment.

What is the total number of KZIA ADS outstanding used in this ownership calculation?

The ownership calculation uses 11,926,899 American Depositary Shares outstanding for KAZIA THERAPEUTICS LTD. This figure assumes all outstanding ordinary shares are represented by ADS and is based on information the issuer provided as of August 19, 2026.

Does Jorey Chernett have sole or shared voting power over his KZIA ADS stake?

Jorey Chernett reports sole voting power over all 2,339,009 KAZIA ADS he beneficially owns. He also reports no shared voting power, meaning no other party is listed as sharing voting authority over these securities.

What dispositive power does Jorey Chernett report over his KZIA holdings?

Jorey Chernett reports sole dispositive power over all 2,339,009 ADS of KAZIA THERAPEUTICS LTD. He indicates no shared dispositive power, so he alone is reported as having the authority to decide on selling or otherwise disposing of these ADS.

What security class of KZIA is covered in this Schedule 13G/A filing?

The filing covers KAZIA THERAPEUTICS LTD American Depositary Shares (ADS). These ADS represent the company’s ordinary shares for U.S. investors, and the reported ownership and percentages all relate specifically to this ADS class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 06:40 PM Accepted by SEC EDGAR 08/19/2026 - 06:40 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

KAZIA THERAPEUTICS LTD

(Name of Issuer)

American Depositary Shares

(Title of Class of Securities)

48669G105

(CUSIP Number)

08/05/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 48669G105

1

Names of Reporting Persons

Chernett Jorey

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,339,009.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,339,009.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,339,009.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

19.6 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KAZIA THERAPEUTICS LTD
(b)	Address of issuer's principal executive offices: THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE, SYDNEY NSW, C3 2000
Item 2.
(a)	Name of person filing: Jorey Chernett (the "Reporting Person")
(b)	Address or principal business office or, if none, residence: The principal business address of the Reporting Person is 6222 Indianwood Trail, Bloomfield Hills, MI 48301.
(c)	Citizenship: US.
(d)	Title of class of securities: American Depositary Shares
(e)	CUSIP No.: 48669G105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The aggregate percentage of American Depositary Shares ("ADS") owned by the Reporting Person is calculated based upon 11,926,899 American Depository Shares outstanding as of August 19, 2026(assuming all outstanding Ordinary Shares were represented by American Depository Shares), based on information provided by the Issuer to the Reporting Person. As of the close of business on August 19, 2026, the Reporting Person beneficially owned 2,339,009 ADS.
(b)	Percent of class: 19.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9.
	(ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9.
	(iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
	(iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/ Jorey Chernett
Name/Title:	Jorey Chernett
Date:	08/19/2026